Arecor Therapeutics plc (AIM:AREC)

Arecor Therapeutics Revenue

Arecor Therapeutics had revenue of 194.00K GBP in the half year ending June 30, 2026, a decrease of -90.28%. This brings the company's total for the last twelve months to 890.00K, down -78.16% year-over-year. In the year 2025, Arecor Therapeutics had annual revenue of 1.71M with 4.32% growth. That makes Arecor Therapeutics the 43,323rd largest company in the world by revenue and 862nd in the United Kingdom.

• Revenue (ttm): 890.00K
• Revenue Growth: -78.16%
• P/S Ratio: 39.45
• Revenue / Employee: 26.97K
• Employees: 33
• Market Cap: 35.11M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe (excl. Uk) & Middle East 1.01M 59.0%
• USA 702.00K 41.0%

Fiscal year ended Dec 31, 2025 See the full Arecor Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.71M	71.00K	4.32%
Dec 31, 2024	1.64M	-2.93M	-64.07%
Dec 31, 2023	4.57M	2.17M	90.30%
Dec 31, 2022	2.40M	1.25M	107.51%
Dec 31, 2021	1.16M	-540.00K	-31.80%
Dec 31, 2020	1.70M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Nov 2, 2026

Data Sources Report a data error